...
首页> 外文期刊>The American Journal of Cardiology >Effect of Adjunctive Thrombus Aspiration on In-Hospital and 3-Year Outcomes in Patients With ST–Segment Elevation Myocardial Infarction and Large Native Coronary Artery Thrombus Burden
【24h】

Effect of Adjunctive Thrombus Aspiration on In-Hospital and 3-Year Outcomes in Patients With ST–Segment Elevation Myocardial Infarction and Large Native Coronary Artery Thrombus Burden

机译:辅助血栓吸入对患有ST段抬高心肌梗死患者的医院和3年结果的影响和大天然冠状动脉血栓负担

获取原文
获取原文并翻译 | 示例
           

摘要

Although the long-term clinical benefit of adjunctive thrombus aspiration (TA) during primary percutaneous coronary intervention (PPCI) remains controversial, the impact of TA in patients with large thrombus has not been evaluated. The aim of the present study was to investigate the effect of adjunctive TA during PPCI on clinical outcomes in patients with ST–segment elevation myocardial infarction (STEMI) and a large thrombus. We assessed the effect of adjunctive TA on in-hospital and 3-year clinical outcomes in 627 patients with STEMI and a large thrombus in the native coronary artery. The cumulative 3-year incidence of all-cause death was not significantly different between the 2 groups (91.5% vs 89.0%, log-rank test p?=?0.347). After adjusting for confounders, the risk of all-cause death in the TA group was not significantly lower than that in the non-TA group (hazard ratio 1.11, 95% confidence interval 0.60 to 3.54, p?=?0.674). The adjusted risks of target lesion revascularization, nonfatal acute myocardial infarction, and stent thrombosis were also not significantly different between the 2 groups. In conclusion, adjunctive TA during PPCI was not associated with better in-hospital and 3-year all-cause deaths in patients with STEMI and a large coronary artery thrombus.
机译:虽然辅助血栓吸入(TA)在初步经皮冠状动脉介入(PPCI)期间的长期临床效益仍然存在争议,但尚未评估TA患者的TA患者的影响。本研究的目的是探讨PPCI期间辅助TA对ST段抬高心肌梗死(STEMI)和大血栓患者临床结果的影响。我们评估了在天然冠状动脉患者中,627例患者在医院内和3年临床结果的影响。 2组之间的全因死亡的累积3年发生率没有显着差异(91.5%vs 89.0%,对数级测试P?= 0.347)。在调整混凝剂后,TA组中全因死亡的风险不会显着低于非TA组(危险比1.11,95%置信区间0.60至3.54,P?0.674)。目标病变血运重建,非急性心肌梗死和支架血栓形成的调整后风险也没有显着差异。总之,PPCI期间的辅助TA与Stemi和大型冠状动脉血栓患者的患者更好的住院医院和3年全因死亡。

著录项

  • 来源
    《The American Journal of Cardiology》 |2017年第10期|共7页
  • 作者单位

    Department of Cardiology Sultan Abdulhamid Han Training and Research Hospital;

    Department of Cardiology Duzce University;

    Texas A&

    M Institute for Preclinical Studies Department of Cardiovascular Sciences Texas A&

    M;

    Training and Research Hospital Department of Cardiology Dr. Siyami Ersek Thoracic and;

    Training and Research Hospital Department of Cardiology Dr. Siyami Ersek Thoracic and;

    Training and Research Hospital Department of Cardiology Dr. Siyami Ersek Thoracic and;

    Training and Research Hospital Department of Cardiology Dr. Siyami Ersek Thoracic and;

    Training and Research Hospital Department of Cardiology Dr. Siyami Ersek Thoracic and;

    Department of Cardiology Sultan Abdulhamid Han Training and Research Hospital;

    Department of Cardiology Sultan Abdulhamid Han Training and Research Hospital;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 心脏、血管(循环系)疾病;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号